NDC properties for "Epogen" (RxCUI 212218)
About this data
The tables show NDC propoerties for Epogen with the RxCUI 212218
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Epogen (RxCUI 212218)
| BLA | BLA103234 |
|---|---|
| MMSL_CODE | BD5690 |
| RxCUI | 212218 |
| SPL_SET_ID | 1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5 |
| Prescribable Synonym | EPOGEN 20,000 UNT/ML Injectable Solution |
| RXNAV_STR | Epogen 20000 UNT/ML Injectable Solution |
| RxNorm Name | epoetin alfa 20000 UNT/ML Injectable Solution [Epogen] |
| RxNorm Synonym | EPO 20000 UNT/ML Injectable Solution [Epogen] |
| RxNorm Synonym | Epogen (epoetin alfa 20,000 UNT/ML) Injectable Solution |
| RxNorm Synonym | Epogen 20000 UNT/ML Injectable Solution |
| RxNorm Synonym | ERYTHROPOIETIN 20000 UNT/ML Injectable Solution [Epogen] |
| Related queries | Interactions (for RxCUI 212218) |
NDC Properties
NDC Item 55513047801
| NDC 9 | 55513-478 |
|---|---|
| NDC 10 | 55513-478-01 |
| NDC Item | 55513047801 |
| Packaging | 1 mL in 1 VIAL |
| BLA | BLA103234 |
| FDA SPL set id | 785837 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1997-03-03 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-478 |
NDC Item 55513047810
| NDC 9 | 55513-478 |
|---|---|
| NDC 10 | 55513-478-10 |
| NDC Item | 55513047810 |
| Packaging | 10 VIAL in 1 PACKAGE (55513-478-10) / 1 mL in 1 VIAL (55513-478-01) |
| BLA | BLA103234 |
| FDA SPL set id | 785837 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1997-03-03 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-478 |
NDC Item 55513047801
| NDC 9 | 55513-478 |
|---|---|
| NDC 10 | 55513-478-01 |
| NDC Item | 55513047801 |
| Packaging | 1 mL in 1 VIAL |
| BLA | BLA103234 |
| FDA SPL set id | 785837 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1997-03-03 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-478 |
NDC Item 55513047810
| NDC 9 | 55513-478 |
|---|---|
| NDC 10 | 55513-478-10 |
| NDC Item | 55513047810 |
| Packaging | 10 VIAL in 1 PACKAGE (55513-478-10) / 1 mL in 1 VIAL (55513-478-01) |
| BLA | BLA103234 |
| FDA SPL set id | 785837 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 1997-03-03 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-478 |